Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Tulpule A, Espina BM, Berman N, Buchanan LH, Smith DL, Sherrod A, Dharmapala D, Gee C, Boswell WD, Nathwani BN, Welles L, Levine AM. Tulpule A, et al. Among authors: welles l. Clin Lymphoma Myeloma. 2006 Jul;7(1):59-64. doi: 10.3816/CLM.2006.n.040. Clin Lymphoma Myeloma. 2006. PMID: 16879771 Clinical Trial.
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L. Levine AM, et al. Among authors: welles l. J Clin Oncol. 2004 Jul 1;22(13):2662-70. doi: 10.1200/JCO.2004.10.093. J Clin Oncol. 2004. PMID: 15226333 Clinical Trial.
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.
Swenson CE, Bolcsak LE, Batist G, Guthrie TH Jr, Tkaczuk KH, Boxenbaum H, Welles L, Chow SC, Bhamra R, Chaikin P. Swenson CE, et al. Among authors: welles l. Anticancer Drugs. 2003 Mar;14(3):239-46. doi: 10.1097/00001813-200303000-00008. Anticancer Drugs. 2003. PMID: 12634619 Clinical Trial.
Activity of thalidomide in AIDS-related Kaposi's sarcoma.
Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R. Little RF, et al. Among authors: welles l. J Clin Oncol. 2000 Jul;18(13):2593-602. doi: 10.1200/JCO.2000.18.13.2593. J Clin Oncol. 2000. PMID: 10893291 Clinical Trial.
A pilot study of cidofovir in patients with kaposi sarcoma.
Little RF, Merced-Galindez F, Staskus K, Whitby D, Aoki Y, Humphrey R, Pluda JM, Marshall V, Walters M, Welles L, Rodriguez-Chavez IR, Pittaluga S, Tosato G, Yarchoan R. Little RF, et al. Among authors: welles l. J Infect Dis. 2003 Jan 1;187(1):149-53. doi: 10.1086/346159. Epub 2002 Dec 13. J Infect Dis. 2003. PMID: 12508160
28 results